|
GB1432562A
(en)
*
|
1972-04-10 |
1976-04-22 |
Rustenburg Platinum Mines Ltd |
Platinum co-ordination compounds
|
|
US4329299A
(en)
*
|
1979-08-23 |
1982-05-11 |
Johnson, Matthey & Co., Limited |
Composition of matter containing platinum
|
|
US4302446A
(en)
*
|
1979-10-02 |
1981-11-24 |
Bristol-Myers Company |
Pharmaceutical compositions
|
|
US4533502A
(en)
*
|
1983-02-22 |
1985-08-06 |
Rochon Fernande D |
Platinum (II) compounds and their preparation
|
|
DE3582961D1
(de)
*
|
1984-06-27 |
1991-07-04 |
Johnson Matthey Plc |
Platinkoordinationsverbindungen.
|
|
US5082655A
(en)
*
|
1984-07-23 |
1992-01-21 |
Zetachron, Inc. |
Pharmaceutical composition for drugs subject to supercooling
|
|
US4902797A
(en)
*
|
1986-12-18 |
1990-02-20 |
Shionogi & Co., Ltd. |
Ammine-alicyclic amine-platinum complexes and antitumor agents
|
|
MX9203808A
(es)
*
|
1987-03-05 |
1992-07-01 |
Liposome Co Inc |
Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
|
|
GB9105037D0
(en)
*
|
1991-03-09 |
1991-04-24 |
Johnson Matthey Plc |
Improvements in chemical compounds
|
|
US5244991A
(en)
*
|
1991-10-15 |
1993-09-14 |
Phillips Petroleum Company |
Olefin polymerization process
|
|
DK0612248T3
(da)
*
|
1991-11-15 |
2003-12-08 |
Smithkline Beecham Corp |
Præparat, der indeholder cisplatin og topotecan som antitumormiddel
|
|
WO1993020235A1
(en)
*
|
1992-04-01 |
1993-10-14 |
The Johns Hopkins University School Of Medicine |
Methods of detecting mammalian nucleic acids isolated from stool specimen and reagents therefor
|
|
US5624919A
(en)
*
|
1993-09-14 |
1997-04-29 |
The University Of Vermont And State Agricultural College |
Trans platinum (IV) complexes
|
|
GB9408218D0
(en)
*
|
1994-04-26 |
1994-06-15 |
Johnson Matthey Plc |
Improvements in platinum complexes
|
|
AU2768295A
(en)
*
|
1994-07-11 |
1996-02-09 |
Hoechst Marion Roussel, Inc. |
Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy
|
|
US5626862A
(en)
*
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
|
US5789000A
(en)
*
|
1994-11-14 |
1998-08-04 |
Bionumerik Pharmaceuticals, Inc. |
Sterile aqueous parenteral formulations of cis-diammine dichloro platinum
|
|
US5919816A
(en)
*
|
1994-11-14 |
1999-07-06 |
Bionumerik Pharmaceuticals, Inc. |
Formulations and methods of reducing toxicity of antineoplastic agents
|
|
GB9502799D0
(en)
*
|
1995-02-14 |
1995-04-05 |
Johnson Matthey Plc |
Improvements in platinum complexes
|
|
US6245349B1
(en)
*
|
1996-02-23 |
2001-06-12 |
éLAN CORPORATION PLC |
Drug delivery compositions suitable for intravenous injection
|
|
US6441025B2
(en)
*
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
|
US5919815A
(en)
*
|
1996-05-22 |
1999-07-06 |
Neuromedica, Inc. |
Taxane compounds and compositions
|
|
NZ333099A
(en)
*
|
1996-06-25 |
2000-06-23 |
Glaxo Group Ltd |
synergistic combinations comprising 141W94, zidovudine and 3TC for use in the treatment of HIV
|
|
DE19847618A1
(de)
*
|
1998-10-15 |
2000-04-20 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
|
US6235782B1
(en)
*
|
1998-11-12 |
2001-05-22 |
Rifat Pamukcu |
Method for treating a patient with neoplasia by treatment with a platinum coordination complex
|
|
DK1165576T3
(da)
*
|
1999-04-13 |
2006-03-27 |
Anormed Inc |
Fremgangsmåde til fremstilling af amin-platin-komplekser
|
|
US6413953B1
(en)
*
|
1999-04-13 |
2002-07-02 |
Anormed Inc. |
Pt(IV) antitumor agent
|
|
GB9925127D0
(en)
*
|
1999-10-22 |
1999-12-22 |
Pharmacia & Upjohn Spa |
Oral formulations for anti-tumor compounds
|
|
US20020102301A1
(en)
*
|
2000-01-13 |
2002-08-01 |
Joseph Schwarz |
Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
|
|
ATE348617T1
(de)
*
|
2000-02-16 |
2007-01-15 |
Astellas Pharma Inc |
Heilmittel gegen durch endothelin verursachte erkrankungen
|
|
US20030027808A1
(en)
*
|
2000-02-29 |
2003-02-06 |
Palmer Peter Albert |
Farnesyl protein transferase inhibitor combinations with platinum compounds
|
|
US20020156033A1
(en)
*
|
2000-03-03 |
2002-10-24 |
Bratzler Robert L. |
Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
|
|
US6545010B2
(en)
*
|
2000-03-17 |
2003-04-08 |
Aventis Pharma S.A. |
Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
|
|
US20020110601A1
(en)
*
|
2000-03-31 |
2002-08-15 |
Roman Perez-Soler |
Antineoplastic platinum therapeutic method and composition
|
|
EE200200565A
(et)
*
|
2000-03-31 |
2004-06-15 |
Angiogene Pharmaceuticals Ltd. |
Vaskulaarse kahjustava toimega kombinatsioonravi
|
|
GB0011903D0
(en)
*
|
2000-05-18 |
2000-07-05 |
Astrazeneca Ab |
Combination chemotherapy
|
|
US7253209B2
(en)
*
|
2000-08-11 |
2007-08-07 |
Dainippon Sumitomo Pharma Co., Ltd. |
Remedies for cisplatin-tolerant cancer
|
|
US6894049B1
(en)
*
|
2000-10-04 |
2005-05-17 |
Anormed, Inc. |
Platinum complexes as antitumor agents
|
|
US6544962B1
(en)
*
|
2000-11-02 |
2003-04-08 |
Matrix Pharmaceutical, Inc. |
Methods for treating cellular proliferative disorders
|
|
SE0004671D0
(sv)
*
|
2000-12-15 |
2000-12-15 |
Amarin Dev Ab |
Pharmaceutical formulation
|
|
JP5009483B2
(ja)
*
|
2001-01-30 |
2012-08-22 |
大日本住友製薬株式会社 |
肺癌治療剤
|
|
AR035227A1
(es)
*
|
2001-02-20 |
2004-05-05 |
Oncolytics Biotech Inc |
Uso de un agente quimioterapeutico para la manufactura de un medicamento para la sensibilizacion de celulas neoplasicas resistentes a agentes quimioterapeuticos con reovirus
|
|
US6673370B2
(en)
*
|
2001-05-15 |
2004-01-06 |
Biomedicines, Inc. |
Oxidized collagen formulations for use with non-compatible pharmaceutical agents
|
|
CN1254233C
(zh)
*
|
2001-08-06 |
2006-05-03 |
阿斯特拉曾尼卡有限公司 |
含有水不溶性的稳定纳米颗粒和赋形剂如中链甘油三酯(mct)的水性分散体
|
|
JP2005502653A
(ja)
*
|
2001-08-20 |
2005-01-27 |
トランセーヴ・インコーポレーテッド |
肺ガンの治療方法
|
|
DE10141528B4
(de)
*
|
2001-08-24 |
2006-08-10 |
Faustus Forschungs Cie. Translational Cancer Research Gmbh |
Platin(II)- und Platin(IV)-Komplexe und ihre Verwendung
|
|
US20030144312A1
(en)
*
|
2001-10-30 |
2003-07-31 |
Schoenhard Grant L. |
Inhibitors of ABC drug transporters in multidrug resistant cancer cells
|
|
AU2002353118A1
(en)
*
|
2001-12-11 |
2003-07-24 |
Dor Biopharma, Inc. |
Lipid particles and suspensions and uses thereof
|
|
US20050119238A1
(en)
*
|
2002-03-01 |
2005-06-02 |
Baron John A. |
Compositions and methods for preventing sporadic neoplasia in colon
|
|
ATE545423T1
(de)
*
|
2002-03-18 |
2012-03-15 |
Dainippon Sumitomo Pharma Co |
Mittel zur behandlung von lungenkrebs
|
|
US20040010553A1
(en)
*
|
2002-07-15 |
2004-01-15 |
International Business Machines Corporation |
Peer to peer location based services
|
|
WO2004006859A2
(en)
*
|
2002-07-16 |
2004-01-22 |
Sonus Pharmaceuticals, Inc. |
Platinum compound
|
|
JP2006502233A
(ja)
*
|
2002-08-02 |
2006-01-19 |
トランセーブ，インク． |
白金凝集物およびその製造方法
|
|
US20040156816A1
(en)
*
|
2002-08-06 |
2004-08-12 |
David Anderson |
Lipid-drug complexes in reversed liquid and liquid crystalline phases
|
|
AU2002951833A0
(en)
*
|
2002-10-02 |
2002-10-24 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods invloving platinum complexes
|
|
US8217010B2
(en)
*
|
2002-10-24 |
2012-07-10 |
The Board Of Trustees Of The University Of Illinois |
Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors
|
|
TWI323662B
(en)
*
|
2002-11-15 |
2010-04-21 |
Telik Inc |
Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
|
|
DE10256182A1
(de)
*
|
2002-12-02 |
2004-06-24 |
Merck Patent Gmbh |
2-Oxadiazolchromonderivate
|
|
US7109337B2
(en)
*
|
2002-12-20 |
2006-09-19 |
Pfizer Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
ES2300672T3
(es)
*
|
2003-04-30 |
2008-06-16 |
Merck Patent Gmbh |
Derivados de cromenona.
|
|
US20050020556A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
|
|
US20070065522A1
(en)
*
|
2004-03-18 |
2007-03-22 |
Transave, Inc. |
Administration of high potency platinum compound formulations by inhalation
|
|
MXPA06013165A
(es)
*
|
2004-05-14 |
2007-02-13 |
Pfizer Prod Inc |
Derivados de pirimidina para el tratamiento de crecimiento de celulas anormal.
|
|
WO2005111024A1
(en)
*
|
2004-05-14 |
2005-11-24 |
Pfizer Products Inc. |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
TW200538149A
(en)
*
|
2004-05-20 |
2005-12-01 |
Telik Inc |
Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound
|
|
TW200600091A
(en)
*
|
2004-05-21 |
2006-01-01 |
Telik Inc |
Sulfonylethyl phosphorodiamidates
|
|
US7378423B2
(en)
*
|
2004-06-11 |
2008-05-27 |
Japan Tobacco Inc. |
Pyrimidine compound and medical use thereof
|
|
EP2298291A3
(en)
*
|
2004-06-18 |
2011-08-03 |
Agennix USA Inc. |
Kinase inhibitors for treating cancers
|
|
US20060003950A1
(en)
*
|
2004-06-30 |
2006-01-05 |
Bone Care International, Inc. |
Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
|
|
US20060058311A1
(en)
*
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
|
JPWO2006028161A1
(ja)
*
|
2004-09-09 |
2008-05-08 |
財団法人乙卯研究所 |
セロトニン５−ｈｔ３受容体作動薬
|
|
EP1793830A2
(en)
*
|
2004-09-22 |
2007-06-13 |
Pfizer, Inc. |
Therapeutic combinations comprising poly(adp-ribose) polymerases inhibitor
|
|
US20060205810A1
(en)
*
|
2004-11-24 |
2006-09-14 |
Schering Corporation |
Platinum therapeutic combinations
|
|
WO2006071812A2
(en)
*
|
2004-12-23 |
2006-07-06 |
H. Lee Moffitt Cancer Center And Research Institute |
Platinum iv complex inhibitor
|
|
US20090047365A1
(en)
*
|
2005-02-28 |
2009-02-19 |
Eisai R & D Management Co., Ltd. |
Novel Concomitant Use of Sulfonamide Compound with Anti-Cancer Agent
|
|
WO2006104668A2
(en)
*
|
2005-03-11 |
2006-10-05 |
Temple University - Of The Commonwealth System Of Higher Education |
Composition and methods for the treatment of proliferative diseases
|
|
JP2006319399A
(ja)
*
|
2005-05-10 |
2006-11-24 |
Nec Electronics Corp |
パルス幅変調回路及び多相クロック生成回路
|
|
EP1888550B1
(en)
*
|
2005-05-12 |
2014-06-25 |
AbbVie Bahamas Ltd. |
Apoptosis promoters
|
|
AU2006284657B2
(en)
*
|
2005-08-31 |
2012-07-19 |
Abraxis Bioscience, Llc |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
|
WO2007056263A2
(en)
*
|
2005-11-08 |
2007-05-18 |
Transave, Inc. |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
|
|
WO2007056264A2
(en)
*
|
2005-11-08 |
2007-05-18 |
Transave, Inc. |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
US20070190181A1
(en)
*
|
2005-11-08 |
2007-08-16 |
Pilkiewicz Frank G |
Methods of treating cancer with lipid-based platinum compound forumulations administered intravenously
|
|
EP1792622A1
(en)
*
|
2005-11-11 |
2007-06-06 |
GPC Biotech AG |
Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and EGFR inhibitors or pyrimidine analogues
|
|
US8158152B2
(en)
*
|
2005-11-18 |
2012-04-17 |
Scidose Llc |
Lyophilization process and products obtained thereby
|
|
US20070122350A1
(en)
*
|
2005-11-30 |
2007-05-31 |
Transave, Inc. |
Safe and effective methods of administering therapeutic agents
|
|
US8143236B2
(en)
*
|
2005-12-13 |
2012-03-27 |
Bionumerik Pharmaceuticals, Inc. |
Chemoprotective methods
|
|
EP2004175A4
(en)
*
|
2006-03-16 |
2010-12-15 |
Bionumerik Pharmaceuticals Inc |
COMPOUNDS AND FORMULATIONS FOR INCREASING THE EFFECT OF CANCER AND METHOD FOR THEIR USE
|
|
US8178564B2
(en)
*
|
2006-11-06 |
2012-05-15 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US8168662B1
(en)
*
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US20110033528A1
(en)
*
|
2009-08-05 |
2011-02-10 |
Poniard Pharmaceuticals, Inc. |
Stabilized picoplatin oral dosage form
|
|
JP2010518088A
(ja)
*
|
2007-02-09 |
2010-05-27 |
ポニアード ファーマシューティカルズ， インコーポレイテッド |
カプセル化されたピコプラチン
|
|
EP2136788B1
(en)
*
|
2007-03-30 |
2011-10-26 |
Bind Biosciences, Inc. |
Cancer cell targeting using nanoparticles
|
|
WO2008150506A1
(en)
*
|
2007-05-31 |
2008-12-11 |
Ascenta Therapeutics, Inc. |
Pulsatile dosing of gossypol for treatment of disease
|
|
TW200916094A
(en)
*
|
2007-06-27 |
2009-04-16 |
Poniard Pharmaceuticals Inc |
Stabilized picoplatin dosage form
|
|
EP2178893A4
(en)
*
|
2007-07-16 |
2012-09-19 |
Poniard Pharmaceuticals Inc |
ORAL FORMULATIONS FOR PICOPLATIN
|
|
WO2009099649A1
(en)
*
|
2008-02-08 |
2009-08-13 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin and bevacizumab to treat colorectal cancer
|
|
US20110025581A1
(en)
*
|
2009-07-31 |
2011-02-03 |
David John Geer |
Antenna assembly
|